Drug-drug Interaction Study with AZD5335 and Itraconazole in Participants with Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Trial Identifier: D8991C00002
Sponsor: AstraZeneca
Start Date: January 2026
Primary Completion Date: October 2027
Study Completion Date: October 2027
Condition: Ovarian Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
ES Barcelona, ES, 08023
ES Logroño, ES, 26006
ES Madrid, ES, 28040
ES Madrid, ES, 28050
GE Batumi, GE, 6010
GE Tbilisi, GE, 0114
GE Tbilisi, GE, 112
IE Dublin, IE, D07 R2WY
PT Lisbon, PT, 1250-068